STOCK TITAN

Merck (NYSE: MRK) EVP Maraldo reports stock, option and RSU holdings

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Merck & Co., Inc. executive David R. Maraldo reports his equity holdings. He holds 17,819.434 shares of common stock directly and 8,359.140 shares through a 401(k) plan. He also holds multiple stock options covering 8,060 to 9,709 shares each, with exercise prices from $73.73 to $129.22, plus restricted stock units for 2,361, 581, and 552 shares that vest in scheduled installments.

Positive

  • None.

Negative

  • None.
Insider Maraldo David R.
Role EVP & Pres. MMD
Type Security Shares Price Value
holding Restricted Stock Unit -- -- --
holding Restricted Stock Unit -- -- --
holding Restricted Stock Unit -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Common Stock -- -- --
holding Common Stock - 401(k) Plan -- -- --
Holdings After Transaction: Restricted Stock Unit — 552 shares (Direct, null); Stock Option (Right to Buy) — 9,465 shares (Direct, null); Common Stock — 17,819.434 shares (Direct, null); Common Stock - 401(k) Plan — 8,359.14 shares (Indirect, By 401 (k))
Footnotes (1)
  1. These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/2/2024, 5/2/2025,and 5/2/2026. Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/30/2025, 4/30/2026, and, 4/30/2027. These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/29/2026, 4/29/2027, and, 4/29/2028. The options became exercisable in equal installments in on 5/4/2022, 5/4/2023, and 5/4/2024. The options became exercisable in equal installments in on 5/5/2024, 5/5/2025, and 5/5/2026. The options vest and become exercisable in equal installments on 5/2/2024, 5/2/2025, and 5/2/2026. The options vest and become exercisable in equal installments on 4/30/2025, 4/30/2026, and 4/30/2027. The options vest and become exercisable in equal installments on 4/29/2026, 4/29/2027, and 4/29/2028.
Direct common stock 17,819.434 shares Total shares following transaction, direct ownership
401(k) common stock 8,359.140 shares Total shares following transaction, indirect via 401(k) plan
Option grant 1 8,060 shares at $84.71 Stock Option (Right to Buy), expires 2035-04-28
Option grant 2 8,789 shares at $129.22 Stock Option (Right to Buy), expires 2034-04-29
Option grant 3 8,990 shares at $117.89 Stock Option (Right to Buy), expires 2033-05-01
Option grant 4 9,709 shares at $87.10 Stock Option (Right to Buy), expires 2032-05-02
RSU grant 1 2,361 units Restricted Stock Unit, vests in three installments to 2028-04-29
RSU grant 2 581 units Restricted Stock Unit, vests in three installments to 2027-04-30
Stock Option (Right to Buy) financial
"security_title": "Stock Option (Right to Buy)""
Restricted Stock Unit financial
"security_title": "Restricted Stock Unit""
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
401(k) Plan financial
"security_title": "Common Stock - 401(k) Plan""
A 401(k) plan is a workplace retirement account that lets employees set aside part of their pay into a tax-advantaged savings pot, often with employers adding matching contributions — like a workplace piggy bank for future income. It matters to investors because the amount people save and how employers fund these plans influence consumer spending, corporate payroll costs and the flow of money into financial markets, which can affect stock prices and company valuations.
exercise price financial
"conversion_or_exercise_price": "84.7100""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date": "2035-04-28T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Maraldo David R.

(Last)(First)(Middle)
126 EAST LINCOLN AVENUE

(Street)
RAHWAY NEW JERSEY 07065

(City)(State)(Zip)

UNITED STATES

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
05/01/2026
3. Issuer Name and Ticker or Trading Symbol
Merck & Co., Inc. [ MRK ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP & Pres. MMD
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock17,819.434D
Common Stock - 401(k) Plan8,359.14IBy 401 (k)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Unit05/02/2024(1)05/02/2026Common Stock552(2)D
Restricted Stock Unit04/30/2025(3)04/30/2027Common Stock581(2)D
Restricted Stock Unit04/29/2026(4)04/29/2028Common Stock2,361(2)D
Stock Option (Right to Buy)05/04/2022(5)05/03/2031Common Stock9,465$73.73D
Stock Option (Right to Buy)05/03/2023(6)05/02/2032Common Stock9,709$87.1D
Stock Option (Right to Buy)05/02/2024(7)05/01/2033Common Stock8,990$117.89D
Stock Option (Right to Buy)04/30/2025(8)04/29/2034Common Stock8,789$129.22D
Stock Option (Right to Buy)04/29/2026(9)04/28/2035Common Stock8,060$84.71D
Explanation of Responses:
1. These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/2/2024, 5/2/2025,and 5/2/2026.
2. Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
3. These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/30/2025, 4/30/2026, and, 4/30/2027.
4. These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/29/2026, 4/29/2027, and, 4/29/2028.
5. The options became exercisable in equal installments in on 5/4/2022, 5/4/2023, and 5/4/2024.
6. The options became exercisable in equal installments in on 5/5/2024, 5/5/2025, and 5/5/2026.
7. The options vest and become exercisable in equal installments on 5/2/2024, 5/2/2025, and 5/2/2026.
8. The options vest and become exercisable in equal installments on 4/30/2025, 4/30/2026, and 4/30/2027.
9. The options vest and become exercisable in equal installments on 4/29/2026, 4/29/2027, and 4/29/2028.
/s/ Kelly E. W. Grez as Attorney-in-Fact for David Maraldo05/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the MRK Form 3 filing for David R. Maraldo show?

The filing shows David R. Maraldo’s initial ownership in Merck stock. It details direct and 401(k) common stock holdings, several stock option grants with specific exercise prices and expirations, and restricted stock units that convert into shares over future vesting dates.

How many Merck common shares does David R. Maraldo hold directly and via 401(k)?

David R. Maraldo directly holds 17,819.434 Merck common shares and indirectly holds 8,359.140 shares through a 401(k) plan. These figures represent his reported beneficial ownership positions as of the transaction date in the filing.

What stock options for Merck (MRK) are reported for David R. Maraldo?

He holds several Stock Option (Right to Buy) positions on Merck common stock, covering 8,060 to 9,709 underlying shares each. Exercise prices range from $73.73 to $129.22, with expiration dates between 2031 and 2035.

What restricted stock units does David R. Maraldo have in Merck?

The filing lists restricted stock units for 2,361, 581, and 552 underlying Merck shares. Footnotes state these RSUs vest and are distributed in three equal installments on specified dates between 2024 and 2028, each unit representing one share.

Do the restricted stock units in MRK automatically convert into common stock?

Each restricted stock unit represents a contingent right to receive one Merck common share. According to the footnotes, these RSUs vest and are distributed as shares in three equal installments on scheduled dates outlined for each grant.

Are there any buy or sell transactions reported in this MRK Form 3?

The data show holding entries only, not explicit purchases or sales. It lists current common stock, option, and restricted stock unit positions, along with vesting and exercisability schedules, rather than reporting new open-market trades or dispositions.